Literature DB >> 20190822

The complicated role of NF-kappaB in T-cell selection.

Mingzhao Zhu1, Yangxin Fu.   

Abstract

The nuclear factor (NF)-kappaB transcription factor family plays important roles in the immune system. Aberrant NF-kappaB signaling is frequently associated with inflammation and autoimmune diseases but the underlying mechanisms are not fully understood. Recent studies show that NF-kappaB plays a critical role in T-cell central tolerance. Two NF-kappaB signaling pathways have been identified: the canonical pathway and the alternative pathway. In the establishment of T-cell central tolerance, the alternative pathway appears to be the key signaling component in thymic stromal cells for their development and function, while the canonical pathway exerts its function more in autonomous T-cell selection. This review intends to summarize the current understanding of the role of NF-kappaB in establishing T-cell central tolerance and highlight unsolved intriguing questions for future work.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190822      PMCID: PMC4001888          DOI: 10.1038/cmi.2009.112

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  54 in total

1.  CCR7 directs the migration of thymocytes into the thymic medulla.

Authors:  Joanne Kwan; Nigel Killeen
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

2.  Cutting edge: developmental switches in chemokine responses during T cell maturation.

Authors:  J J Campbell; J Pan; E C Butcher
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

3.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Expression of relB is required for the development of thymic medulla and dendritic cells.

Authors:  L Burkly; C Hession; L Ogata; C Reilly; L A Marconi; D Olson; R Tizard; R Cate; D Lo
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

5.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Luke M Williams; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

6.  Requirement for NF-kappaB in osteoclast and B-cell development.

Authors:  G Franzoso; L Carlson; L Xing; L Poljak; E W Shores; K D Brown; A Leonardi; T Tran; B F Boyce; U Siebenlist
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

7.  RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts.

Authors:  Y Xia; S Chen; Y Wang; N Mackman; G Ku; D Lo; L Feng
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

8.  I kappa B kinase complex alpha kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue.

Authors:  Danielle L Drayton; Giuseppina Bonizzi; Xiaoyan Ying; Shan Liao; Michael Karin; Nancy H Ruddle
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

Review 9.  Expanded nuclear roles for IkappaBs.

Authors:  Paul W Bates; Shigeki Miyamoto
Journal:  Sci STKE       Date:  2004-10-12

10.  CCR7 signals are essential for cortex-medulla migration of developing thymocytes.

Authors:  Tomoo Ueno; Fumi Saito; Daniel H D Gray; Sachiyo Kuse; Kunio Hieshima; Hideki Nakano; Terutaka Kakiuchi; Martin Lipp; Richard L Boyd; Yousuke Takahama
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  17 in total

Review 1.  Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel "first-in-class" anti-inflammatory drug candidates: a reviewer's perspective.

Authors:  Geetha Mathew; M K Unnikrishnan
Journal:  Inflamm Res       Date:  2015-07-18       Impact factor: 4.575

Review 2.  Regulation of nuclear factor-κB in autoimmunity.

Authors:  Shao-Cong Sun; Jae-Hoon Chang; Jin Jin
Journal:  Trends Immunol       Date:  2013-02-20       Impact factor: 16.687

Review 3.  Thymic epithelial cell development and differentiation: cellular and molecular regulation.

Authors:  Lina Sun; Haiying Luo; Hongran Li; Yong Zhao
Journal:  Protein Cell       Date:  2013-04-15       Impact factor: 14.870

Review 4.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development.

Authors:  Hongbo Hu; Xuefeng Wu; Wei Jin; Mikyoung Chang; Xuhong Cheng; Shao-Cong Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

Review 6.  TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex.

Authors:  Jian-hong Shi; Shao-Cong Sun
Journal:  Mol Immunol       Date:  2015-08-08       Impact factor: 4.407

Review 7.  Vitamin D and influenza.

Authors:  Maria E Sundaram; Laura A Coleman
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

Review 8.  Thymic epithelial cell development and its dysfunction in human diseases.

Authors:  Lina Sun; Hongran Li; Haiying Luo; Yong Zhao
Journal:  Biomed Res Int       Date:  2014-02-03       Impact factor: 3.411

Review 9.  Ubiquitin signaling in immune responses.

Authors:  Hongbo Hu; Shao-Cong Sun
Journal:  Cell Res       Date:  2016-03-25       Impact factor: 25.617

10.  VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.

Authors:  David Labrousse-Arias; Emma Martínez-Alonso; María Corral-Escariz; Raquel Bienes-Martínez; Jaime Berridy; Leticia Serrano-Oviedo; Elisa Conde; María-Laura García-Bermejo; José M Giménez-Bachs; Antonio S Salinas-Sánchez; Ricardo Sánchez-Prieto; Masahiro Yao; Marina Lasa; María J Calzada
Journal:  J Cell Biol       Date:  2017-02-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.